Pathogenic mutations in non-BRCA homologous repair deficiency (HRD) genes were identified in four other patients, one each of RAD51B, RAD51C, RAD51D, PALB2 and BRIP1 (0.5% mutation rate for all). This evidence concerns the gene PALB2 and hypoparathyroidism-retardation-dysmorphism syndrome.